The Third Italian Consensus Conference for Malignant Pleural Mesothelioma: State of the art and recommendations.
Malignant pleural mesothelioma (MPM) is the most common primary malignancy of the pleura. The occurrence of malignant mesothelioma is typically related to exposure to mineral fibers such as asbestos and erionite.[1‐3] Reports suggest that genetic factors may also play a role in MPM. Moreover, latency periods that are the period of time between the first exposure to asbestos and a disease diagnosis range from 20 to 50 years. The mortality burden from asbestos‐related diseases (ARD) is heavy and ARD accounts for 92,250 deaths per year globally. To improve survival of MPM patients, effective strategy of early diagnosis and effective treatment strategies are highly needed.